000 | 01007 a2200301 4500 | ||
---|---|---|---|
005 | 20250515222053.0 | ||
264 | 0 | _c20100722 | |
008 | 201007s 0 0 ger d | ||
022 | _a1615-1003 | ||
024 | 7 |
_a10.1002/pauz.201090025 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEdris, E | |
245 | 0 | 0 |
_a[Antisense against cancer?]]. _h[electronic resource] |
260 |
_bPharmazie in unserer Zeit _cMay 2010 |
||
300 |
_a170-1 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoxia-Inducible Factor 1 _xbiosynthesis |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aOligonucleotides _xtherapeutic use |
650 | 0 | 4 |
_aOligonucleotides, Antisense _xtherapeutic use |
700 | 1 | _aMöller, A-M | |
700 | 1 | _aOberhauser, E M | |
700 | 1 | _aZündorf, I | |
700 | 1 | _aDingermann, T | |
773 | 0 |
_tPharmazie in unserer Zeit _gvol. 39 _gno. 3 _gp. 170-1 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/pauz.201090025 _zAvailable from publisher's website |
999 |
_c19782637 _d19782637 |